[Comparative studies of plasma and urine levels between uremic peak 2a and guanidino compounds].
作者信息
Koide K, Toyama J, Inoue N, Koshikawa S, Akizawa T, Takahashi K, Hidaka S, Yamane Y, Nakao M, Ono S
出版信息
Nihon Jinzo Gakkai Shi. 1987 Apr;29(4):485-92.
PMID:3656706
Abstract
摘要
相似文献
1
[Comparative studies of plasma and urine levels between uremic peak 2a and guanidino compounds].尿毒症峰2a与胍基化合物之间血浆和尿液水平的比较研究
Nihon Jinzo Gakkai Shi. 1987 Apr;29(4):485-92.
2
[Nitrogen metabolism and chronic renal insufficiency].[氮代谢与慢性肾功能不全]
Bull Mem Soc Med Hop Paris. 1968;119(12):977-80.
3
[On the behavior of phenols and creatinine in renal insufficiency, especilly in chronic dialysis patients].
Arch Klin Med. 1968;214(3):214-43.
4
The presence and toxicity of guanidinoproprionic acid in uremia.尿毒症中胍基丙酸的存在及毒性
Kidney Int Suppl. 1975 Feb(3):302-5.
5
[Changes of guanidino compounds in chronic renal failure (author's transl)].慢性肾功能衰竭中胍基化合物的变化（作者译）
Nihon Jinzo Gakkai Shi. 1979 Jan;21(1):33-49.
6
[Oxalate behavior in patients undergoing periodic hemodialytic treatments].[接受定期血液透析治疗患者的草酸盐行为]
Minerva Nefrol. 1970 Nov-Dec;17(6):184-6.
7
[Chronic renal failure and guanidino compounds].
Yakugaku Zasshi. 1997 Nov;117(10-11):673-80. doi: 10.1248/yakushi1947.117.10-11_673.
8
Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
Ren Fail. 1999 Sep;21(5):499-514. doi: 10.3109/08860229909045190.
9
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
10
Zinc metabolism in uremia.尿毒症中的锌代谢
J Lab Clin Med. 1979 Nov;94(5):693-8.
Zotero 插件